Thyroid Cancer Drugs Market Global Scenario, Market Size, Outlook, Trend, and Forecast, 2019 – 2028

TABLE OF CONTENTS

Chapter 1        Prefix

1.1    Market Scope

1.2    Report Description

1.3    Research Methodology

1.3.1      Primary Research

1.3.2      Secondary Research

1.3.3      In-house Data Modeling

Chapter 2        Executive Summary

2.1   Global Thyroid Cancer Drugs Market Year-on-Year Growth, 2020 - 2028 (%)

Chapter 3        Market Outline

3.1    Market Inclination, Trend, Outlook and Viewpoint

3.2    Market Share Analysis: Company’s Competitive Scenario

3.3    Value Chain Analysis

3.4    Porter’s Five Forces Analysis

3.5    Market Dynamics

3.5.1      Drivers

3.5.1.1      Impact Analysis

3.5.2      Restraints

3.5.2.1      Impact Analysis

3.5.3      Opportunities

Chapter 4        Global Thyroid Cancer Drugs Market by Type: Market Size and Forecast, 2019 – 2028

4.1    Overview

4.2  Thyroid Cancer

4.2.1    Current Trend and Analysis

4.2.2    Market Size and Forecast, 2019 - 2028 ($ Billion)

4.2.3    Market Size and Forecast by Region, 2019 - 2028 ($ Billion)

4.3  Hurthle Cell Cancer

4.3.1    Current Trend and Analysis

4.3.2    Market Size and Forecast, 2019 - 2028 ($ Billion)

4.3.3    Market Size and Forecast by Region, 2019 - 2028 ($ Billion)

4.4  Follicular Thyroid Cancer

4.4.1    Current Trend and Analysis

4.4.2    Market Size and Forecast, 2019 - 2028 ($ Billion)

4.4.3    Market Size and Forecast by Region, 2019 - 2028 ($ Billion)

4.5  Anaplastic Thyroid Cancer

4.5.1    Current Trend and Analysis

4.5.2    Market Size and Forecast, 2019 - 2028 ($ Billion)

4.5.3    Market Size and Forecast by Region, 2019 - 2028 ($ Billion)

4.6  Medullary Thyroid Cancer (MTC)

4.6.1    Current Trend and Analysis

4.6.2    Market Size and Forecast, 2019 - 2028 ($ Billion)

4.6.3    Market Size and Forecast by Region, 2019 - 2028 ($ Billion)

Chapter 5        Global Thyroid Cancer Drugs Market by Treatment: Market Size and Forecast, 2019 – 2028  

5.1  Overview

5.2  Medication

5.2.1    Current Trend and Analysis

5.2.2    Market Size and Forecast, 2019 - 2028 ($ Billion)

5.2.3    Market Size and Forecast by Region, 2019 - 2028 ($ Billion)

5.3  Radioactive Iodine (Radioiodine) Therapy

5.3.1    Current Trend and Analysis

5.3.2    Market Size and Forecast, 2019 - 2028 ($ Billion)

5.3.3    Market Size and Forecast by Region, 2019 - 2028 ($ Billion)

5.4  Hormone Therapy

5.4.1    Current Trend and Analysis

5.4.2    Market Size and Forecast, 2019 - 2028 ($ Billion)

5.4.3    Market Size and Forecast by Region, 2019 - 2028 ($ Billion)

5.5  Chemotherapy

5.5.1    Current Trend and Analysis

5.5.2    Market Size and Forecast, 2019 - 2028 ($ Billion)

5.5.3    Market Size and Forecast by Region, 2019 - 2028 ($ Billion)

5.6  Surgery

5.6.1      Near- total Thyroidectomy

5.6.1.1  Current Trend and Analysis

5.6.1.2  Market Size and Forecast, 2019 - 2028 ($ Billion)

5.6.1.3  Market Size and Forecast by Region, 2019 - 2028 ($ Billion)

5.6.2      Total Thyroidectomy and Lobectomy

5.6.2.1  Current Trend and Analysis

5.6.2.2  Market Size and Forecast, 2019 - 2028 ($ Billion)

5.6.2.3  Market Size and Forecast by Region, 2019 - 2028 ($ Billion)

Chapter 6        Global Thyroid Cancer Drugs Market by Drug Type: Market Size and Forecast, 2019 – 2028

6.1  Overview

6.2  Ipilimumab

6.2.1      Current Trend and Analysis

6.2.2      Market Size and Forecast, 2019 - 2028 ($ Billion)

6.2.3      Market Size and Forecast by Region, 2019 - 2028 ($ Billion)

6.3  Cabozantinib-S-Malate

6.3.1      Current Trend and Analysis

6.3.2      Market Size and Forecast, 2019 - 2028 ($ Billion)

6.3.3      Market Size and Forecast by Region, 2019 - 2028 ($ Billion)

6.4  Caprelsa (Vandetanib)

6.4.1      Current Trend and Analysis

6.4.2      Market Size and Forecast, 2019 - 2028 ($ Billion)

6.4.3      Market Size and Forecast by Region, 2019 - 2028 ($ Billion)

6.5  Doxorubicin Hydrochloride

6.5.1      Current Trend and Analysis

6.5.2      Market Size and Forecast, 2019 - 2028 ($ Billion)

6.5.3      Market Size and Forecast by Region, 2019 - 2028 ($ Billion)

6.6  Cometriq (Cabozantinib-S-Malate)

6.6.1      Current Trend and Analysis

6.6.2      Market Size and Forecast, 2019 - 2028 ($ Billion)

6.6.3      Market Size and Forecast by Region, 2019 - 2028 ($ Billion)

6.7  Lenvatinib Mesylate

6.7.1      Current Trend and Analysis

6.7.2      Market Size and Forecast, 2019 - 2028 ($ Billion)

6.7.3      Market Size and Forecast by Region, 2019 - 2028 ($ Billion)

6.8  Nivolumab

6.8.1      Current Trend and Analysis

6.8.2      Market Size and Forecast, 2019 - 2028 ($ Billion)

6.8.3      Market Size and Forecast by Region, 2019 - 2028 ($ Billion)

6.9  Vandetanib

6.9.1      Current Trend and Analysis

6.9.2      Market Size and Forecast, 2019 - 2028 ($ Billion)

6.9.3      Market Size and Forecast by Region, 2019 - 2028 ($ Billion)

6.10   Others

6.10.1   Current Trend and Analysis

6.10.2   Market Size and Forecast, 2019 - 2028 ($ Billion)

6.10.3   Market Size and Forecast by Region, 2019 - 2028 ($ Billion)

Chapter 7        Global Thyroid Cancer Drugs Market by Route of Administration: Market Size and Forecast, 2019 – 2028

7.1  Overview

7.2  Injectable

7.2.1      Current Trend and Analysis

7.2.2      Market Size and Forecast, 2019 - 2028 ($ Billion)

7.2.3      Market Size and Forecast by Region, 2019 - 2028 ($ Billion)

7.3  Oral

7.3.1      Current Trend and Analysis

7.3.2      Market Size and Forecast, 2019 - 2028 ($ Billion)

7.3.3      Market Size and Forecast by Region, 2019 - 2028 ($ Billion)

7.4  Others

7.4.1      Current Trend and Analysis

7.4.2      Market Size and Forecast, 2019 - 2028 ($ Billion)

7.4.3      Market Size and Forecast by Region, 2019 - 2028 ($ Billion)

Chapter 8        Global Thyroid Cancer Drugs Market by End Users: Market Size and Forecast, 2019 – 2028

8.1  Overview

8.2  Hospitals

8.2.1      Current Trend and Analysis

8.2.2      Market Size and Forecast, 2019 - 2028 ($ Billion)

8.2.3      Market Size and Forecast by Region, 2019 - 2028 ($ Billion)

8.3  Oncology Clinics

8.3.1      Current Trend and Analysis

8.3.2      Market Size and Forecast, 2019 - 2028 ($ Billion)

8.3.3      Market Size and Forecast by Region, 2019 - 2028 ($ Billion)

8.4  Research Organizations

8.4.1      Current Trend and Analysis

8.4.2      Market Size and Forecast, 2019 - 2028 ($ Billion)

8.4.3      Market Size and Forecast by Region, 2019 - 2028 ($ Billion)

8.5  Others

8.5.1      Current Trend and Analysis

8.5.2      Market Size and Forecast, 2019 - 2028 ($ Billion)

8.5.3      Market Size and Forecast by Region, 2019 - 2028 ($ Billion)

Chapter 9        Global Thyroid Cancer Drugs Market by Geography: Market Size and Forecast, 2019 – 2028 

9.1  Overview

9.1.1    Global Thyroid Cancer Drugs Market Year-on-Year Growth, by region 2020 – 2028 (%)

9.2  North America

9.2.1    Current Trend and Analysis

9.2.2    Market Size and Forecast, 2019 - 2028 ($ Billion)

9.2.3    U.S.

9.2.3.1        Market Size and Forecast, 2019 - 2028 ($ Billion)

9.2.3.2        By Type

9.2.3.3        By Treatment

9.2.3.4        By Drug Type

9.2.3.5        By Route of Administration

9.2.3.6        By End Users

9.2.4    Canada

9.2.4.1        Market Size and Forecast, 2019 - 2028 ($ Billion)

9.2.4.2        By Type

9.2.4.3        By Treatment

9.2.4.4        By Drug Type

9.2.4.5        By Route of Administration

9.2.4.6        By End Users

9.2.5    Mexico

9.2.5.1        Market Size and Forecast, 2019 - 2028 ($ Billion)

9.2.5.2        By Type

9.2.5.3        By Treatment

9.2.5.4        By Drug Type

9.2.5.5        By Route of Administration

9.2.5.6        By End Users

9.2.6    Rest of North America

9.2.6.1        Market Size and Forecast, 2019 - 2028 ($ Billion)

9.2.6.2        By Type

9.2.6.3        By Treatment

9.2.6.4        By Drug Type

9.2.6.5        By Route of Administration

9.2.6.6        By End Users

9.3    Europe

9.3.1    Current Trend and Analysis

9.3.2    Market Size and Forecast, 2019 - 2028 ($ Billion)

9.3.3    UK

9.3.3.1        Market Size and Forecast, 2019 - 2028 ($ Billion)

9.3.3.2        By Type

9.3.3.3        By Treatment

9.3.3.4        By Drug Type

9.3.3.5        By Route of Administration

9.3.3.6        By End Users

9.3.4    Russia

9.3.4.1        Market Size and Forecast, 2019 - 2028 ($ Billion)

9.3.4.2        By Type

9.3.4.3        By Treatment

9.3.4.4        By Drug Type

9.3.4.5        By Route of Administration

9.3.4.6        By End Users

9.3.5    France

9.3.5.1        Market Size and Forecast, 2019 - 2028 ($ Billion)

9.3.5.2        By Type

9.3.5.3        By Treatment

9.3.5.4        By Drug Type

9.3.5.5        By Route of Administration

9.3.5.6        By End Users

9.3.6    Italy

9.3.6.1        Market Size and Forecast, 2019 - 2028 ($ Billion)

9.3.6.2        By Type

9.3.6.3        By Treatment

9.3.6.4        By Drug Type

9.3.6.5        By Route of Administration

9.3.6.6        By End Users

9.3.7    Germany

9.3.7.1        Market Size and Forecast, 2019 - 2028 ($ Billion)

9.3.7.2        By Type

9.3.7.3        By Treatment

9.3.7.4        By Drug Type

9.3.7.5        By Route of Administration

9.3.7.6        By End Users

9.3.8    Rest of Europe

9.3.8.1        Market Size and Forecast, 2019 - 2028 ($ Billion)

9.3.8.2        By Type

9.3.8.3        By Treatment

9.3.8.4        By Drug Type

9.3.8.5        By Route of Administration

9.3.8.6        By End Users

9.4    Asia-Pacific

9.4.1    Current Trend and Analysis

9.4.2    Market Size and Forecast, 2019 - 2028 ($ Billion)

9.4.3    China

9.4.3.1        Market Size and Forecast, 2019 - 2028 ($ Billion)

9.4.3.2        By Type

9.4.3.3        By Treatment

9.4.3.4        By Drug Type

9.4.3.5        By Route of Administration

9.4.3.6        By End Users

9.4.4    India

9.4.4.1        Market Size and Forecast, 2019 - 2028 ($ Billion)

9.4.4.2        By Type

9.4.4.3        By Treatment

9.4.4.4        By Drug Type

9.4.4.5        By Route of Administration

9.4.4.6        By End Users

9.4.5    Japan

9.4.5.1        Market Size and Forecast, 2019 - 2028 ($ Billion)

9.4.5.2        By Type

9.4.5.3        By Treatment

9.4.5.4        By Drug Type

9.4.5.5        By Route of Administration

9.4.5.6        By End Users

9.4.6    Rest of Asia-Pacific

9.4.6.1        Market Size and Forecast, 2019 - 2028 ($ Billion)

9.4.6.2        By Type

9.4.6.3        By Treatment

9.4.6.4        By Drug Type

9.4.6.5        By Route of Administration

9.4.6.6        By End Users

9.5    RoW

9.5.1    Current Trend and Analysis

9.5.2    Market Size and Forecast

9.5.3    South America

9.5.3.1        Market Size and Forecast, 2019 - 2028 ($ Billion)

9.5.3.2        By Type

9.5.3.3        By Treatment

9.5.3.4        By Drug Type

9.5.3.5        By Route of Administration

9.5.3.6        By End Users

9.5.4    Middle East

9.5.4.1        Market Size and Forecast, 2019 - 2028 ($ Billion)

9.5.4.2        By Type

9.5.4.3        By Treatment

9.5.4.4        By Drug Type

Back to top

Payment Options

Single User $3971.25
$5295
Five User $4646.25
$6195
Enterprise $6149.25
$8199
Datapack $1649.25
$2199
Short Report: $2324.25
$3099